Article: ALLERGAN LIGAND RETINOID THERAPEUTICS INC. SUBSCRIPTION OFFERING DECLARED EFFECTIVE BY SEC

SAN DIEGO and IRVINE, Calif., May 5 /PRNewswire/ -- Ligand Pharmaceuticals Incorporated (Nasdaq-NNM: LGND) and Allergan Inc. (NYSE: AGN) announced today that the Securities and Exchange Commission declared effective the registration statement filed by Ligand and Allergan Ligand Retinoid Therapeutics, Inc. (ALRT) relating to a rights offering to stockholders of Ligand and stockholders of Allergan. Rights issued in the offering will be distributed to stockholders of Ligand and stockholders of Allergan of record at the close of business on May 5, 1995 (the "Record Date") and will trade on the Nasdaq National Market commencing on May 8, 1995 through 4 p.m., New York City time ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!